 | Up a level |
Jain, Tania; Estrada-Merly, Noel; Salas, M Queralt; Kim, Soyoung; DeVos, Jakob D; Chen, Min; Fang, Xi; Kumar, Rajat; Andrade-Campos, Marcio; Elmariah, Hany; Agrawal, Vaibhav; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M; Ballen, Karen Kuhn; Beitinjaneh, Amer; Bhatt, Vijaya R; Bredeson, Christopher N; DeFilipp, Zachariah; ... (2024). Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study. Blood advances, 8(16), pp. 4281-4293. American Society of Hematology 10.1182/bloodadvances.2024013451
Pabst, Thomas; Bacher, Ulrike (2024). Boosting CAR T cells against lymphomas. Blood, 144(7), pp. 689-691. American Society of Hematology 10.1182/blood.2024025378
Ayçiçek, Selin G; Akhoundova, Dilara; Bacher, Ulrike; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R.; Pabst, Thomas (2024). Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation. International journal of molecular sciences, 25(15) MDPI 10.3390/ijms25158215
Martinez Flores, Danaë; Akhoundova, Dilara; Seipel, Katja; Legros, Myriam; Kronig, Marie-Noelle; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2024). Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines, 12(7) MDPI 10.3390/biomedicines12071616
Tavakolidakhrabadi, Amirmahdi; Stark, Matt; Bacher, Ulrike; Legros, Myriam; Bessire, Cedric (2024). Optimization of Microfluidics for Point-of-Care Blood Sensing. Biosensors, 14(6) MDPI 10.3390/bios14060266
Eggimann, Matthias; Akhoundova, Dilara; Nilius, Henning; Hoffmann, Michèle; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2024). Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers, 16(10) MDPI AG 10.3390/cancers16101887
Mehl, Julian; Akhoundova, Dilara; Bacher, Ulrike; Jeker, Barbara; Rhyner Agocs, Gaëlle; Ruefer, Axel; Soltermann, Susanne; Soekler, Martin; Winkler, Annette; Daskalakis, Michael; Pabst, Thomas (2024). Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery. Cancers, 16(10) MDPI AG 10.3390/cancers16101854
Aydilek, Enver; Wulf, Gerald; Schwarz, Friedrich; Bacher, Ulrike; Rummel, Mathias; Stiefel, Olga; Kerkhoff, Andrea; Maulhardt, Markus; Melchardt, Thomas; Pabst, Thomas; Lenz, Georg; Shumilov, Evgenii (2024). Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe. Cancer medicine, 13(10) Wiley 10.1002/cam4.7289
Hoffmann, Michèle; Banz, Yara; Halter, Jörg; Schoumans, Jacqueline; Tchinda, Joëlle; Bacher, Ulrike; Pabst, Thomas (2024). True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report. Current oncology, 31(4), pp. 2067-2075. MDPI 10.3390/curroncol31040153
Seipel, Katja; Mandhair, Harpreet; Bacher, Ulrike; Pabst, Thomas (2024). FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology, 46(4), pp. 2946-2960. MDPI 10.3390/cimb46040184
Berning, Philipp; Shumilov, Evgenii; Maulhardt, Markus; Boyadzhiev, Hristo; Kerkhoff, Andrea; Call, Simon; Reicherts, Christian; Saidy, Anna O.; Aydilek, Enver; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Schmitz, Norbert; Stelljes, Matthias; Wulf, Gerald; Bacher, Ulrike; Lenz, Georg; Pabst, Thomas Niklaus (2024). Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study. HemaSphere, 8(3), pp. 1-12. Wiley 10.1002/hem3.54
Heini, Alexander D; Bacher, Ulrike; Pabst, Thomas (2024). Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL). British journal of haematology, 204(2), pp. 389-390. Wiley-Blackwell 10.1111/bjh.19195
Klyuchnikov, Evgeny; Badbaran, Anita; Massoud, Radwan; Freiberger, Petra; Wolschke, Christine; Ayuk, Francis; Fehse, Boris; Bacher, Ulrike; Kröger, Nicolaus (2024). Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR. Leukemia, 38(2), pp. 386-388. Nature Publishing Group 10.1038/s41375-024-02148-3
Perroud, Camille; Thurian, Dario; Andres, Martin; Künzi, Arnaud; Wiedemann, Gertrud; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas; Banz, Yara; Porret, Naomi; Rebmann, Ekaterina (2023). Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological oncology, 41(5), pp. 912-921. Wiley 10.1002/hon.3208
Shumilov, Evgenii; Boyadzhiev, Hristo; Mazzeo, Paolo; Akhoundova, Dilara; Daskalakis, Michael; Novak, Urban; Lenz, Georg; Bacher, Ulrike; Pabst, Thomas (2023). CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement. HemaSphere, 7(12), e984. Wolters Kluwer Health 10.1097/HS9.0000000000000984
Bacher, Ulrike; Shumilov, Evgenii; Pabst, Thomas (2023). Benefit of repeated COVID-19 vaccination for patients with B-cell malignancies. British journal of haematology, 202(6), pp. 1081-1083. Wiley-Blackwell 10.1111/bjh.19005
Messerli, Christian; Wiedemann, Gertrud; Porret, Naomi; Nagler, Michael; Seipel, Katja; Jeker, Barbara; Novak, Urban; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas (2023). Correlation of peripheral chimeric antigen receptor T-cell (CAR-T cell) mRNA expression levels with toxicities and outcome in patients with diffuse large B-cell lymphoma (DLBCL). Turkish journal of haematology, 40(3), pp. 187-196. Turkish Society of Haematology 10.4274/tjh.galenos.2023.2023.0136
Seipel, Katja; Kohler, Scarlett; Bacher, Ulrike; Pabst, Thomas (2023). HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology, 45(9), pp. 7011-7026. MDPI 10.3390/cimb45090443
Tamari, Roni; McLornan, Donal P; Ahn, Kwang Woo; Estrada-Merly, Noel; Hernandez-Boluda, Juan Carlos; Giralt, Sergio A; Palmer, Jeanne M; Gale, Robert Peter; DeFilipp, Zachariah; Marks, David; van der Poel, Marjolein W M; Verdonck, Leo F; Battiwalla, Minoo; Díaz, Miguel A; Gupta, Vikas; Ali, Haris; Litzow, Mark R; Lazarus, Hillard M; Gergis, Usama; Bashey, Asad; ... (2023). A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis. Blood advances, 7(15), pp. 3993-4002. American Society of Hematology 10.1182/bloodadvances.2023009886
Maechler, Melanie; Bacher, Ulrike; Daskalakis, Michael; Nilius, Henning; Nagler, Michael; Mansouri Taleghani, Behrouz; Jeker, Barbara; Pabst, Thomas (2023). Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients. Hematological oncology, 41(3), pp. 583-586. Wiley 10.1002/hon.3055
Pabst, Thomas; Vey, Norbert; Adès, Lionel; Bacher, Ulrike; Bargetzi, Mario; Fung, Samson; Gaidano, Gianluca; Gandini, Domenica; Hultberg, Anna; Johnson, Amy; Ma, Xuewen; Müller, Rouven; Nottage, Kerri; Papayannidis, Cristina; Recher, Christian; Riether, Carsten; Shah, Priya; Tryon, Jeffrey; Xiu, Liang and Ochsenbein, Adrian F (2023). Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. Haematologica - the hematology journal, 108(7), pp. 1793-1802. Ferrata-Storti Foundation 10.3324/haematol.2022.281563
von Matt, Stefanie; Bacher, Ulrike; Banz, Yara; Mansouri Taleghani, Behrouz; Novak, Urban; Pabst, Thomas (2023). Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment. Mediterranean journal of hematology and infectious diseases, 15(1), e2023025. Università Cattolica del Sacro Cuore 10.4084/MJHID.2023.025
Boyiadzis, Michael; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M; Battiwalla, Minoo; Bejanyan, Nelli; Bhatt, Vijaya Raj; Brown, Valerie I; Castillo, Paul; Cerny, Jan; Copelan, Edward A; Craddock, Charles; Dholaria, Bhagirathbhai; Perez, Miguel Angel Diaz; Ebens, Christen L; ... (2023). Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia, 37(5), pp. 1006-1017. Springer Nature 10.1038/s41375-022-01738-3
Boyiadzis, Michael; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M; Battiwalla, Minoo; Bejanyan, Nelli; Bhatt, Vijaya Raj; Brown, Valerie I; Castillo, Paul; Cerny, Jan; Copelan, Edward A; Craddock, Charles; Dholaria, Bhagirathbhai; Perez, Miguel Angel Diaz; Ebens, Christen L; ... (2023). Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia, 37(5), p. 1173. Springer Nature 10.1038/s41375-023-01814-2
Akhoundova Sanoyan, Dilara; Seipel, Katja; Bacher, Ulrike; Kronig, Marie-Noelle; Porret, Naomi; Wiedemann, Gertrud; Daskalakis, Michael; Pabst, Thomas (2023). Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients. BMC cancer, 23(1), p. 345. BioMed Central 10.1186/s12885-023-10824-3
Huwyler, Fabrizio; Kunz, Rebekka; Bacher, Ulrike; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Banz, Yara; Pabst, Thomas (2023). Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma. Cancers, 15(7) MDPI AG 10.3390/cancers15072091
Heini, Alexander D; Beck, Philipp; Bacher, Ulrike; Seipel, Katja; Zander, Thilo; Daskalakis, Michael; Pabst, Thomas (2023). BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of Clinical Medicine, 12(6) MDPI 10.3390/jcm12062378
Wittibschlager, Valerie; Bacher, Ulrike; Seipel, Katja; Porret, Naomi; Wiedemann, Gertrud; Haslebacher, Claudia; Hoffmann, Michèle; Daskalakis, Michael; Akhoundova, Dilara; Pabst, Thomas (2023). CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences, 24(6) MDPI 10.3390/ijms24065688
Lakomy, Tim; Akhoundova, Dilara; Nilius, Henning; Kronig, Marie-Noëlle; Novak, Urban; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules, 13(2) MDPI 10.3390/biom13020382
Klyuchnikov, Evgeny; Langebrake, Claudia; Badbaran, Anita; Dadkhah, Adrin; Massoud, Radwan; Freiberger, Petra; Ayuk, Francis; Janson, Dietlinde; Wolschke, Christine; Bacher, Ulrike; Kröger, Nicolaus (2023). Individualized busulfan dosing improves outcomes compared to fixed dose administration in pre-transplant MRD positive AML patients with intermediate risk undergoing allogeneic stem cell transplantation in CR. European journal of haematology, 110(2), pp. 188-197. Wiley 10.1111/ejh.13893
Bühler, Selina; Akhoundova, Dilara; Jeker, Barbara; Legros, Myriam; Seipel, Katja; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers, 15(2) MDPI AG 10.3390/cancers15020430
Mei, Matthew; Pillai, Raju; Kim, Soyoung; Estrada-Merly, Noel; Afkhami, Michelle; Yang, Lixin; Meng, Zhuo; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Beitinjaneh, Amer; Bredeson, Christopher; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; Cutler, Corey; DeFilipp, Zachariah; Diaz Perez, Miguel Angel; Farhadfar, Nosha; Freytes, César O; ... (2023). The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis. Haematologica - the hematology journal, 108(1), pp. 150-160. Ferrata-Storti Foundation 10.3324/haematol.2021.280203
Bohler, Jeanne; Bacher, Ulrike; Banz, Yara; Stadelmann, Raphael; Medinger, Michael; Zander, Thilo; Pabst, Thomas (2023). Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers, 15(1), p. 44. MDPI AG 10.3390/cancers15010044
Seipel, Katja; Frey, Michèle; Nilius, Henning; Akhoundova, Dilara; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2023). Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology, 30(12), pp. 10463-10476. MDPI 10.3390/curroncol30120762
Krekeler, Carolin; Reitnauer, Lea; Bacher, Ulrike; Khandanpour, Cyrus; Steger, Leander; Boeckel, Göran Ramin; Klosner, Justine; Tepasse, Phil-Robin; Kemper, Marcel; Hennies, Marc Tim; Mesters, Rolf; Stelljes, Matthias; Schmitz, Norbert; Kerkhoff, Andrea; Schliemann, Christoph; Mikesch, Jan-Henrik; Schmidt, Nicole; Lenz, Georg; Bleckmann, Annalen and Shumilov, Evgenii (2022). Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario. Cancers, 14(22) MDPI AG 10.3390/cancers14225512
Seipel, Katja; Brügger, Yvo; Mandhair, Harpreet; Bacher, Ulrike; Pabst, Thomas (2022). Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. International journal of molecular sciences, 23(20) MDPI 10.3390/ijms232012587
Rebmann Chigrinova, Ekaterina; Porret, Naomi A; Andres, Martin; Wiedemann, Gertrud; Banz, Yara; Legros, Myriam; Pollak, Matthias; Oppliger Leibundgut, Elisabeth; Pabst, Thomas; Bacher, Ulrike (2022). Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias. BMC medical genomics, 15(1), p. 203. BioMed Central 10.1186/s12920-022-01346-1
Rausch, Christian; Bacher, Ulrike; Rabaglio, Manuela; Vorburger, Corinne; Klingenberg, Anke; Banz, Yara; Daskalakis, Michael; Pabst, Thomas (2022). Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study. Journal of clinical medicine, 11(18) MDPI 10.3390/jcm11185378
Heini, Alexander D; Bacher, Ulrike; Porret, Naomi; Wiedemann, Gertrud; Legros, Myriam; Stalder Zeerleder, Denise; Seipel, Katja; Novak, Urban; Daskalakis, Michael; Pabst, Thomas (2022). Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells, 11(17) MDPI 10.3390/cells11172747
Shumilov, Evgenii; Aperdannier, Lena; Schmidt, Nicole; Szuszies, Christoph; Neesse, Albrecht; Hoffknecht, Petra; Khandanpour, Cyrus; Mikesch, Jan-Henrik; Stelljes, Matthias; Boeckel, Göran Ramin; Tepasse, Phil-Robin; Reitnauer, Lea; Koch, Raphael; Hasenkamp, Justin; Bacher, Ulrike; Scheithauer, Simone; Trümper, Lorenz; Schmitz, Norbert; Wulf, Gerald; Kerkhoff, Andrea; ... (2022). Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis. Cancers, 14(15) MDPI AG 10.3390/cancers14153746
Gössi, Simona; Bacher, Ulrike; Haslebacher, Claudia; Nagler, Michael; Suter, Franziska; Staehelin, Cornelia; Novak, Urban; Pabst, Thomas (2022). Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy. Cancers, 14(14) MDPI AG 10.3390/cancers14143527
Klyuchnikov, Evgeny; Badbaran, Anita; Massoud, Radwan; Fritsche-Friedland, Ulrike; Freiberger, Petra; Ayuk, Francis; Wolschke, Christine; Bacher, Ulrike; Kröger, Nicolaus (2022). Post-transplant day +100 MRD detection rather than mixed chimerism predicts relapses after allo-SCT for intermediate risk AML patients transplanted in CR. Transplantation and cellular therapy, 28(7), 374.e1-374.e9. Elsevier 10.1016/j.jtct.2022.04.009
Stoffel, Tanja; Bacher, Ulrike; Banz, Yara; Daskalakis, Michael; Novak, Urban; Pabst, Thomas (2022). BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study. Journal of clinical medicine, 11(13) MDPI 10.3390/jcm11133748
Heini, Alexander D; Bacher, Ulrike; Kronig, Marie-Noëlle; Wiedemann, Gertrud; Novak, Urban; Zeerleder, Sacha; Mansouri Taleghani, Behrouz; Daskalakis, Michael; Pabst, Thomas (2022). Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center. Bone marrow transplantation, 57(6), pp. 1010-1012. Springer Nature 10.1038/s41409-022-01658-x
Farag, Sarah; Bacher, Ulrike; Jeker, Barbara; Legros, Myriam; Rhyner, Gaelle; Lüthi, Jean-Marc; Schardt, Julian; Zander, Thilo; Daskalakis, Michael; Mansouri, Behrouz; Manz, Chantal; Pabst, Thomas (2022). Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial. Bone marrow transplantation, 57(6), pp. 990-997. Springer Nature 10.1038/s41409-022-01681-y
Rentsch, Vera; Seipel, Katja; Banz, Yara; Wiedemann, Gertrud; Porret, Naomi; Bacher, Ulrike; Pabst, Thomas (2022). Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy. Cancers, 14(10) MDPI AG 10.3390/cancers14102516
Klyuchnikov, Evgeny; Badbaran, Anita; Massoud, Radwan; Fritsche-Friedland, Ulrike; Janson, Dietlinde; Ayuk, Francis; Christopeit, Maximilian; Wolschke, Christine; Bacher, Ulrike; Kröger, Nicolaus (2022). Post-Transplantation Multicolored Flow Cytometry–Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia. Transplantation and cellular therapy, 28(5), 267.e1-267.e7. Elsevier 10.1016/j.jtct.2022.01.014
Jimenez Jimenez, Antonio M; De Lima, Marcos; Komanduri, Krishna V; Wang, Trent P; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Alkhateeb, Hassan; Assal, Amer; Bacher, Ulrike; Baron, Frédéric; Battiwalla, Minoo; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; ... (2022). Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone marrow transplantation, 57(5), p. 852. Springer Nature 10.1038/s41409-022-01625-6
Mathys, Anina; Bacher, Ulrike; Banz, Yara; Legros, Myriam; Mansouri Taleghani, Behrouz; Novak, Urban; Pabst, Thomas (2022). Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era Letter. Hematological oncology, 40(2), pp. 292-296. Wiley 10.1002/hon.2952
Murthy, Hemant S; Ahn, Kwang Woo; Estrada-Merly, Noel; Alkhateeb, Hassan B; Bal, Susan; Kharfan-Dabaja, Mohamed A; Dholaria, Bhagirathbhai; Foss, Francine; Gowda, Lohith; Jagadeesh, Deepa; Sauter, Craig; Abid, Muhammad Bilal; Aljurf, Mahmoud; Awan, Farrukh T; Bacher, Ulrike; Badawy, Sherif M; Battiwalla, Minoo; Bredeson, Chris; Cerny, Jan; Chhabra, Saurabh; ... (2022). Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplantation and cellular therapy, 28(4), 187.e1-187.e10. Elsevier 10.1016/j.jtct.2022.01.017
Guru Murthy, Guru Subramanian; Kim, Soyoung; Hu, Zhen-Huan; Estrada-Merly, Noel; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Badawy, Sherif M; Beitinjaneh, Amer; Bredeson, Chris; Cahn, Jean-Yves; Cerny, Jan; Diaz Perez, Miguel Angel; Farhadfar, Nosha; Gale, Robert Peter; Ganguly, Siddhartha; Gergis, Usama; Hildebrandt, Gerhard C; Grunwald, Michael R; Hashmi, Shahrukh; ... (2022). Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors. JAMA oncology, 8(3), pp. 404-411. American Medical Association 10.1001/jamaoncol.2021.6846
Sidler, Daniel; Born, Alexander; Schietzel, Simeon; Horn, Michael P; Aeberli, Daniel; Amsler, Jennifer; Möller, Burkhard; Njue, Linet M; Medri, Cesare; Angelillo-Scherrer, Anne; Borradori, Luca; Jafari, S Morteza Seyed; Radonjic-Hoesli, Susanne; Chan, Andrew; Hoepner, Robert; Bacher, Ulrike; Mani, Laila-Yasmin; Iype, Joseena Mariam; Suter-Riniker, Franziska; Staehelin, Cornelia; ... (2022). Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy. RMD open, 8(1) BMJ Publishing Group 10.1136/rmdopen-2021-002166
Gurevich, Ekaterina; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2022). Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers, 14(4) MDPI AG 10.3390/cancers14041024
Shumilov, Evgenii; Vehling-Kaiser, Ursula; Damnali, Gamze; Schulz, Xenia; Kaiser, Ulrich; Bacher, Ulrike; Kaiser, Florian (2022). Oral and Subcutaneous Anticancer Therapy Training Course for Non-physician Healthcare Professionals: a Survey Evaluating the Relevance of its Content and its Implications in the Practice of Cancer Care. Journal of cancer education, 37(1), pp. 120-127. Springer 10.1007/s13187-020-01794-2
Shumilov, Evgenii; Shakhanova, Inna; Flach, Johanna; Schmidt, Nicole; Buerki, Susanne; Legros, Myriam; Kronig, Marie-Noëlle; Ofran, Yishai; Gerull, Sabine; Medinger, Michael; Mansouri Taleghani, Behrouz; Passweg, Jakob; Halter, Jörg; Bacher, Ulrike; Pabst, Thomas (2022). Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation. Bone marrow transplantation, 57(2), pp. 224-231. Springer Nature 10.1038/s41409-021-01521-5
Wieduwilt, Matthew J; Metheny, Leland; Zhang, Mei-Jie; Wang, Hai-Lin; Estrada-Merly, Noel; Marks, David I; Al-Homsi, A Samar; Muffly, Lori; Chao, Nelson J; Rizzieri, David; Gale, Robert Peter; Gadalla, Shahinaz M; Cairo, Mitchell S; Mussetti, Alberto; Gore, Steven D; Bhatt, Vijaya Raj; Patel, Sagar S; Michelis, Fotios V; Inamoto, Yoshihiro; Badawy, Sherif M; ... (2022). Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood advances, 6(1), pp. 339-357. American Society of Hematology 10.1182/bloodadvances.2021004916
Menghrajani, Kamal; Gomez-Arteaga, Alexandra; Madero-Marroquin, Rafael; Zhang, Mei-Jie; Bo-Subait, Khalid; Sanchez, Jonathan; Wang, Hai-Lin; Aljurf, Mahmoud; Assal, Amer; Bacher, Ulrike; Badawy, Sherif M; Bejanyan, Nelli; Bhatt, Vijaya Raj; Bredeson, Christopher N; Byrne, Michael; Castillo, Paul; Cerny, Jan; Chhabra, Saurabh; Ciurea, Stefan Octavian; DeFilipp, Zachariah; ... (2022). Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances, 6(3), pp. 828-847. American Society of Hematology 10.1182/bloodadvances.2021004881
Jimenez Jimenez, Antonio M; De Lima, Marcos; Komanduri, Krishna V; Wang, Trent P; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Alkhateeb, Hassan; Assal, Amer; Bacher, Ulrike; Baron, Frédéric; Battiwalla, Minoo; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; ... (2021). An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone marrow transplantation, 56(12), pp. 3068-3077. Springer Nature 10.1038/s41409-021-01450-3
Messmer, Anna S; Que, Yok-Ai; Schankin, Christoph; Banz, Yara; Bacher, Ulrike; Novak, Urban; Pabst, Thomas (2021). CAR T-cell therapy and critical care : A survival guide for medical emergency teams. Wiener klinische Wochenschrift, 133(23-24), pp. 1318-1325. Springer-Verlag 10.1007/s00508-021-01948-2
Metheny, Leland; Callander, Natalie S; Hall, Aric C; Zhang, Mei-Jei; Bo-Subait, Khalid; Wang, Hai-Lin; Agrawal, Vaibhav; Al-Homsi, A Samer; Assal, Amer; Bacher, Ulrike; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya Raj; Bredeson, Chris; Byrne, Michael; Cairo, Mitchell; Cerny, Jan; DeFilipp, Zachariah; Perez, Miguel Angel Diaz; Freytes, César O; ... (2021). Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults. Transplantation and cellular therapy, 27(11), 923.e1-923.e12. Elsevier 10.1016/j.jtct.2021.08.010
Oran, Betül; Ahn, Kwang Woo; Fretham, Caitrin; Beitinjaneh, Amer; Bashey, Asad; Pawarode, Attaphol; Wirk, Baldeep; Scott, Bart L; Savani, Bipin N; Bredeson, Christopher; Weisdorf, Daniel; Marks, David I; Rizzieri, David; Copelan, Edward; Hildebrandt, Gerhard C; Hale, Gregory A; Murthy, Hemant S; Lazarus, Hillard M; Cerny, Jan; Liesveld, Jane L; ... (2021). Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplantation and cellular therapy, 27(11), 921.e1-921.e10. Elsevier 10.1016/j.jtct.2021.08.007
Condoluci, Adalgisa; Théaudin, Marie; Schwotzer, Rahel; Pazhenkottil, Aju P; Arosio, Paolo; Averaimo, Manuela; Bacher, Ulrike; Bode, Peter; Cavalli, Andrea; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Gerull, Sabine; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2021). Management of transthyretin amyloidosis. Swiss medical weekly, 151(w30053), w30053. EMH Media 10.4414/smw.2021.w30053
Messmer, Anna Sarah; Que, Yok-Ai; Schankin, Christoph; Banz, Yara; Bacher, Ulrike; Novak, Urban; Pabst, Thomas (2021). Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland. Critical care explorations, 3(10), e0552. Wolters Kluwer Health 10.1097/CCE.0000000000000552
Percival, Mary-Elizabeth; Wang, Hai-Lin; Zhang, Mei-Jie; Saber, Wael; de Lima, Marcos; Litzow, Mark; Kebriaei, Partow; Abdel-Azim, Hisham; Adekola, Kehinde; Aljurf, Mahmoud; Bacher, Ulrike; Badawy, Sherif M; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya; Byrne, Michael; Cahn, Jean-Yves; Castillo, Paul; Chao, Nelson; Chhabra, Saurabh; ... (2021). Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation. Bone marrow transplantation, 56(9), pp. 2108-2117. Springer Nature 10.1038/s41409-021-01261-6
Percival, Mary-Elizabeth; Wang, Hai-Lin; Zhang, Mei-Jie; Saber, Wael; de Lima, Marcos; Litzow, Mark; Kebriaei, Partow; Abdel-Azim, Hisham; Adekola, Kehinde; Aljurf, Mahmoud; Bacher, Ulrike; Badawy, Sherif M; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya; Byrne, Michael; Cahn, Jean-Yves; Castillo, Paul; Chao, Nelson; Chhabra, Saurabh; ... (2021). Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation. Bone marrow transplantation, 56(9), p. 2319. Springer Nature 10.1038/s41409-021-01353-3
Lazaryan, Aleksandr; Dolan, Michelle; Zhang, Mei-Jie; Wang, Hai-Lin; Kharfan-Dabaja, Mohamed A; Marks, David I; Bejanyan, Nelli; Copelan, Edward; Majhail, Navneet S; Waller, Edmund K; Chao, Nelson; Prestidge, Tim; Nishihori, Taiga; Kebriaei, Partow; Inamoto, Yoshihiro; Hamilton, Betty; Hashmi, Shahrukh K; Kamble, Rammurti T; Bacher, Ulrike; Hildebrandt, Gerhard C; ... (2021). Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica - the hematology journal, 106(8), pp. 2295-2296. Ferrata-Storti Foundation 10.3324/haematol.2021.279046
Damonti, Lauro; Buetti, Niccolò; Droz, Sara; Bacher, Ulrike; Pabst, Thomas; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela Maria; Marschall, Jonas (2021). Prevalence and significance of bacterial contamination of autologous stem cell products. The journal of hospital infection, 114, pp. 175-179. Elsevier 10.1016/j.jhin.2021.04.006
Heini, Alexander D.; Porret, Naomi; Zenhaeusern, Reinhard; Winkler, Annette; Bacher, Ulrike; Pabst, Thomas (2021). Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML. Cancers, 13(13) MDPI AG 10.3390/cancers13133190
Shumilov, Evgenii; Hoffknecht, Petra; Koch, Raphael; Peceny, Rudolf; Voigt, Steffen; Schmidt, Nicole; Peeck, Micha; Bacher, Ulrike; Scheithauer, Simone; Trümper, Lorenz; Lenz, Georg; Kerkhoff, Andrea; Bleckmann, Annalen (2021). Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers. Cancers, 13(12) MDPI AG 10.3390/cancers13122917
Chanias, Ioannis; Stojkov, Kristina; Stehle, Gregor Th.; Daskalakis, Michael; Simeunovic, Helena; Njue, Linet Muthoni; Schnegg-Kaufmann, Annatina S.; Porret, Naomi A.; Allam, Ramanjaneyulu; Tata, Nageswara Rao; Benz, Rudolf; Ruefer, Axel; Schmidt, Adrian; Adler, Marcel; Rovo, Alicia; Balabanov, Stefan; Stuessi, Georg; Bacher, Ulrike; Bonadies, Nicolas (2021). Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine. Cancers, 13(13) MDPI AG 10.3390/cancers13133296
Klyuchnikov, Evgeny; Christopeit, Maximilian; Badbaran, Anita; Bacher, Ulrike; Fritsche-Friedland, Ulrike; von Pein, Ute-Marie; Wolschke, Christine; Kröger, Nicolaus (2021). Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML. European journal of haematology, 106(5), pp. 606-615. Wiley-Blackwell 10.1111/ejh.13557
Bonadies, Nicolas; Rovó, Alicia; Porret, Naomi; Bacher, Ulrike (2021). When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis. Journal of clinical medicine, 10(5) MDPI 10.3390/jcm10051026
Pabst, Thomas; Bacher, Ulrike (2021). Risk stratification systems for allogeneic haematopoietic stem-cell transplantation. The Lancet. Haematology, 8(3), e166-e167. Elsevier 10.1016/S2352-3026(20)30403-8
Seipel, Katja; Kopp, Basil; Bacher, Ulrike; Pabst, Thomas (2021). BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers, 13(3) MDPI AG 10.3390/cancers13030581
Betticher, Christophe; Bacher, Ulrike; Legros, Myriam; Zimmerli, Stefan; Banz, Yara; Mansouri Taleghani, Behrouz; Pabst, Thomas (2021). Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation. Hematological oncology, 39(1), pp. 97-104. Wiley 10.1002/hon.2813
Brechbühl, Simon; Bacher, Ulrike; Jeker, Barbara; Pabst, Thomas (2021). Real-World Outcome in the pre-CAR-T Era of Myeloma Patients Qualifying for CAR-T Cell Therapy. Mediterranean journal of hematology and infectious diseases, 13(1), e2021012. Università Cattolica del Sacro Cuore 10.4084/MJHID.2021.012
Nydegger, Anna; Novak, Urban; Kronig, Marie-Noëlle; Legros, Myriam; Zeerleder, Sacha; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2021). Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients. Cancers, 13(23) MDPI AG 10.3390/cancers13236073
Chanias, Ioannis; Wilk, C Matthias; Benz, Rudolf; Daskalakis, Michael; Stüssi, Georg; Schmidt, Adrian; Bacher, Ulrike; Bonadies, Nicolas (2020). Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement. International journal of environmental research and public health, 17(24) MDPI 10.3390/ijerph17249562
Hu, Bei; Lin, Xiao; Lee, Hans C; Huang, Xuelin; Tidwell, Rebecca S Slack; Ahn, Kwang Woo; Hu, Zhen-Huan; Jabbour, Elias; Verstovsek, Srdan; Ravandi, Farhad; Garcia-Manero, Guillermo; Kharfan-Dabaja, Mohamed A; Hossain, Nasheed M; Marks, David I; Kamble, Rammuriti T; Inamoto, Yoshihiro; Kindwall-Keller, Tamila; Saad, Ayman; Litzow, Mark R; Savani, Bipin N; ... (2020). Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients. Leukemia & lymphoma, 61(12), pp. 2811-2820. Taylor & Francis 10.1080/10428194.2020.1783444
Nazha, Aziz; Hu, Zhen-Huan; Wang, Tao; Lindsley, R Coleman; Abdel-Azim, Hisham; Aljurf, Mahmoud; Bacher, Ulrike; Bashey, Asad; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; DeFilipp, Zachariah; Diaz, Miguel Angel; Farhadfar, Nosha; Gadalla, Shahinaz M; Gale, Robert Peter; George, Biju; Gergis, Usama; Grunwald, Michael R; Hamilton, Betty; ... (2020). A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes. Biology of blood and marrow transplantation, 26(11), pp. 2139-2146. Elsevier 10.1016/j.bbmt.2020.08.003
Idle, Jeffrey R; Seipel, Katja; Bacher, Ulrike; Pabst, Thomas; Beyoğlu, Diren (2020). (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers, 12(10) MDPI AG 10.3390/cancers12102842
Jeker, Barbara; Farag, Sarah; Mansouri Taleghani, Behrouz; Novak, Urban; Mueller, Beatrice U; Li, Qiyu; Betticher, Daniel; Luethi, Jean-Marc; Farese, Simone; Ruefer, Axel; Bacher, Ulrike; Pabst, Thomas (2020). A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients. Bone marrow transplantation, 55(10), pp. 2047-2051. Springer Nature 10.1038/s41409-020-0875-8
Flach, Johanna; Shumilov, Evgenii; Wiedemann, Gertrud; Porret, Naomi; Shakhanova, Inna; Bürki, Susanne; Legros, Myriam; Joncourt, Raphael; Pabst, Thomas; Bacher, Ulrike (2020). Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia. Hematological oncology, 38(4), pp. 425-431. Wiley 10.1002/hon.2739
Riether, Carsten; Pabst, Thomas; Höpner, Sabine; Bacher, Ulrike; Hinterbrandner, Magdalena; Banz, Yara; Müller, Rouven; Manz, Markus G.; Gharib, Walid H.; Francisco, David; Bruggmann, Remy; van Rompaey, Luc; Moshir, Mahan; Delahaye, Tim; Gandini, Domenica; Erzeel, Ellen; Hultberg, Anna; Fung, Samson; de Haard, Hans; Leupin, Nicolas; ... (2020). Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nature medicine, 26(9), pp. 1459-1467. Springer Nature 10.1038/s41591-020-0910-8
Schmidt, Sarah; Liu, Ying; Hu, Zhen-Huan; Williams, Kirsten M; Lazarus, Hillard M; Vij, Ravi; Kharfan-Dabaja, Mohamed A; Ortí, Guillermo; Wiernik, Peter H; Weisdorf, Daniel; Kamble, Rammurti T; Herzig, Roger; Wirk, Baldeep; Cerny, Jan; Bacher, Ulrike; Chaudhri, Naeem A; Nathan, Sunita; Farhadfar, Nosha; Aljurf, Mahmoud; Gergis, Usama; ... (2020). The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biology of blood and marrow transplantation, 26(6), pp. 1137-1143. Elsevier 10.1016/j.bbmt.2020.02.006
Jagadeesh, Deepa; Majhail, Navneet S; He, Yizeng; Ahn, Kwang W; Litovich, Carlos; Ahmed, Sairah; Aljurf, Mahmoud; Bacher, Ulrike; Badawy, Sherif M; Bejanyan, Nelli; Cairo, Mitchell; Cerny, Jan; Epperla, Narendranath; Farhadfar, Nosha; Freytes, César O; Gale, Robert Peter; Haverkos, Bradley; Hossain, Nasheed; Inwards, David; Kamble, Rammurti T; ... (2020). Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. Cancer, 126(10), pp. 2279-2287. John Wiley & Sons 10.1002/cncr.32752
Gowin, Krisstina; Ballen, Karen; Ahn, Kwang Woo; Hu, Zhen-Huan; Ali, Haris; Arcasoy, Murat O; Devlin, Rebecca; Coakley, Maria; Gerds, Aaron T; Green, Michael; Gupta, Vikas; Hobbs, Gabriela; Jain, Tania; Kandarpa, Malathi; Komrokji, Rami; Kuykendall, Andrew T; Luber, Kierstin; Masarova, Lucia; Michaelis, Laura C; Patches, Sarah; ... (2020). Survival following allogeneic transplant in patients with myelofibrosis. Blood advances, 4(9), pp. 1965-1973. American Society of Hematology 10.1182/bloodadvances.2019001084
Flach, Johanna; Shumilov, Evgenii; Joncourt, Raphael; Porret, Naomi; Novak, Urban; Pabst, Thomas; Bacher, Ulrike (2020). Current concepts and future directions for hemato-oncologic diagnostics. Critical reviews in oncology, hematology, 151, p. 102977. Elsevier 10.1016/j.critrevonc.2020.102977
Lazaryan, Aleksandr; Dolan, Michelle; Zhang, Mei-Jie; Wang, Hai-Lin; Kharfan-Dabaja, Mohamed A; Marks, David I; Bejanyan, Nelli; Copelan, Edward; Maijhail, Navneet; Waller, Edmund K; Chao, Nelson; Prestidge, Tim; Nishihori, Taiga; Kebriaei, Partow; Inamoto, Yoshihiro; Hamilton, Betty; Hashmi, Shahrukh K; Kamble, Rammurti T; Bacher, Ulrike; Hildebrandt, Gerhard C; ... (2020). Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica - the hematology journal, 105(5), pp. 1329-1338. Ferrata-Storti Foundation 10.3324/haematol.2019.220756
DeFilipp, Zachariah; Ancheta, Richard; Liu, Ying; Hu, Zhen-Huan; Gale, Robert Peter; Snyder, David; Schouten, Harry C; Kalaycio, Matt; Hildebrandt, Gerhard C; Ustun, Celalettin; Daly, Andrew; Ganguly, Siddhartha; Inamoto, Yoshihiro; Litzow, Mark; Szer, Jeffrey; Savoie, Mary Lynn; Hossain, Nasheed; Kharfan-Dabaja, Mohamed A; Hamadani, Mehdi; Reshef, Ran; ... (2020). Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study. Biology of blood and marrow transplantation, 26(3), pp. 472-479. Elsevier 10.1016/j.bbmt.2019.10.017
Heini, Alexander D.; Hugo, Rebecca; Berger, Martin D.; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). A simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia. Hematological oncology, 38(1), pp. 74-81. Wiley 10.1002/hon.2696
Seipel, Katja; Messerli, Christian; Wiedemann, Gertrud; Bacher, Ulrike; Pabst, Thomas (2020). MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation. Leukemia research, 89(106296), p. 106296. Elsevier 10.1016/j.leukres.2020.106296
De Santiago de Benito, Alvaro; Jeker, Barbara; Gfeller, Eva; Porret, Naomi; Banz, Yara; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia. Haematologica - the hematology journal, 105(1), e9-e12. Ferrata-Storti Foundation 10.3324/haematol.2019.216457
Flach, Johanna; Shumilov, Evgenii; Porret, Naomi; Shakhanova, Inna; Legros, Myriam; Kronig, Marie-Noëlle; Joncourt, Raphael; Bacher, Ulrike; Pabst, Thomas (2020). Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series. Mediterranean journal of hematology and infectious diseases, 12(1), e2020068. Università Cattolica del Sacro Cuore 10.4084/MJHID.2020.068
Seipel, Katja; Schmitter, Karin; Bacher, Ulrike; Pabst Müller, Thomas Niklaus (2019). Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia. Cancers, 11(11) MDPI AG 10.3390/cancers11111779
Kim, Haesook T; Ahn, Kwang Woo; Hu, Zhen-Huan; Davids, Matthew S; Volpe, Virginia O; Antin, Joseph H; Sorror, Mohamed L; Shadman, Mazyar; Press, Oliver; Pidala, Joseph; Hogan, William; Negrin, Robert; Devine, Steven; Uberti, Joseph; Agura, Edward; Nash, Richard; Mehta, Jayesh; McGuirk, Joseph; Forman, Stephen; Langston, Amelia; ... (2019). Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report. Clinical cancer research, 25(16), pp. 5143-5155. American Association for Cancer Research 10.1158/1078-0432.CCR-18-3988
Amsler, Isabel G; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Luethi, Jean-Marc; Novak, Urban; Pabst, Thomas (2019). Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma. Leukemia & lymphoma, 60(2), pp. 511-514. Taylor & Francis 10.1080/10428194.2018.1473577
Shumilov, Evgenyi; Novak, Urban; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2019). Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients. HemaSphere, 3(2), e176. Wolters Kluwer Health 10.1097/HS9.0000000000000176
Schnell, Bianca R.; Seipel, Katja; Bacher, Ulrike; Jeker, Barbara; Mueller, Beatrice U.; Banz, Yara; Novak, Urban; Pabst, Thomas (2019). Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. HemaSphere, 3(2), e180. Wolters Kluwer Health 10.1097/HS9.0000000000000180
Shumilov, Evgenii; Flach, Johanna; Kohlmann, Alexander; Banz Wälti, Yara; Bonadies, Nicolas; Fiedler, Martin; Pabst, Thomas; Bacher, Ulrike (2018). Current status and trends in the diagnostics of AML and MDS. Blood reviews, 32(6), pp. 508-519. Elsevier 10.1016/j.blre.2018.04.008
Shumilov, Evgenii; Bacher, Ulrike; Perske, Christina; Mohr, Alexander; Eiffert, Helmut; Hasenkamp, Justin; Trümper, Lorenz; Wulf, Gerald G; Ströbel, Philipp; Ibrahim, Ashraf S; Venkataramani, Vivek (2018). Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis. Antimicrobial agents and chemotherapy, 62(5) American Society for Microbiology 10.1128/AAC.00172-18
Schanz, Julie; Cevik, Naciye; Fonatsch, Christa; Braulke, Friederike; Shirneshan, Katayoon; Bacher, Ulrike; Haase, Detlef (2018). Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders. Blood cancer journal, 8(3), p. 28. Nature Publishing Group 10.1038/s41408-018-0061-z
Oyekunle, Anthony; Shumilov, Evgenii; Kostrewa, Philippe; Burchert, Andreas; Trümper, Lorenz; Wuchter, Patrick; Wulf, Gerald; Bacher, Ulrike; Kröger, Nicolaus (2018). Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens. Biology of blood and marrow transplantation, 24(2), pp. 276-281. Elsevier 10.1016/j.bbmt.2017.10.008
